<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The progression of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> to esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> is partly driven by chromosomal alterations that activate oncogenes and inactivate <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes </plain></SENT>
<SENT sid="1" pm="."><plain>The goal of this study was to determine how alterations of 4 frequently affected genes correlate with the range of histopathologic lesions observed in resected esophagi of patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Fluorescence in situ hybridization was used to assess 83 tissue sections from 10 <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> esophagogastrectomy specimens for chromosomal alterations of 8q24 (MYC), 9p21 (CDKN2A; alias P16), 17q12 (ERBB2), and 20q13.2 (ZNF217) </plain></SENT>
<SENT sid="3" pm="."><plain>Histologic lesions assessed included <z:mp ids='MP_0005213'>gastric metaplasia</z:mp> (n = 8), <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (n = 43), low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 28), high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 25), and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n = 16) </plain></SENT>
<SENT sid="4" pm="."><plain>Histologic maps showing the correlation between fluorescence in situ hybridization abnormalities and corresponding histology were created for <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="5" pm="."><plain>Chromosomal abnormalities included 9p21 loss, single locus gain, and polysomy </plain></SENT>
<SENT sid="6" pm="."><plain>A greater number of chromosomal alterations were detected as the severity of histologic diagnosis increased from <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had alterations involving the CDKN2A gene </plain></SENT>
<SENT sid="8" pm="."><plain>CDKN2A loss was the only abnormality detected in 20 (47%) of 43 areas of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Polysomy, the most common abnormality in dysplastic epithelium and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, was observed in 16 (57%) of 28 low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, 22 (88%) of 25 high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, and 16 (100%) of 16 <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>The findings of this study improve our understanding of the role that <z:mp ids='MP_0008866'>chromosomal instability</z:mp> and alterations of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes such as CDKN2A and oncogenes such as ERBB2 play in the progression of <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
</text></document>